People · Operator
Named in public records as an officer, director or promoter · active 2015–2020 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vavotar Life Sciences LLC | — | Other Health Care | Series C | $156.0M | $228.6M | 2016 |
| Rion LLC | — | Biotechnology | Series B | $25.4M | $693.5M | 2017 |
| H-Cyte, Inc. | — | Other Health Care | Series A | $14.6M | $58.1M | 2016 |
| AperiSys, Inc. | — | Other Health Care | Seed | $6.2M | $16.9M | 2015 |
Charles Farrahar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Farrahar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Gorlin | 4 | 11 |
| John Preston | 1 | 7 |
| John C. Thomas, Jr. | 1 | 5 |
| William E. Horne | 1 | 4 |
| Larry Papasan | 1 | 3 |
| Andrew Danielsen | 1 | 3 |
| John Blank | 1 | 2 |
| John Thomas, Jr. | 1 | 2 |
| JAMES A ROGERS | 1 | 2 |
| Jeffrey Wright | 1 | 2 |
| Peter Gerhard | 1 | 2 |
| Randal R. Betz | 1 | 2 |
| Jesse W. Crowne | 1 | 2 |
| James Andrews | 1 | 2 |
| Scott Haufe | 1 | 1 |
| C.A. Hennies | 1 | 1 |
| Jeffery Wright | 1 | 1 |
| Randal Betz | 1 | 1 |
| Thomas M. Hills | 1 | 1 |
| Dennis Moon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.